Loading…
Based on limited metadata, KratomNC received an FDA Warning Letter on May 16, 2019, regarding the marketing and/or distribution of kratom products classified as drugs. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined, though FDA drug warning letters typically address unauthorized drug claims, manufacturing deficiencies, or regulatory non-compliance. The warning falls under FDA's drug product oversight authority, though the specific issuing office is not identified in the available metadata.